Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Natl Cancer Inst. 1996 Jun 19;88(12):779-81.

How much can we rely on the level of prostate-specific antigen as an end point for evaluation of clinical trials? A word of caution!

Comment on

PMID:
8637038
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire
    Loading ...
    Write to the Help Desk